PetMed Express, Inc.
PETS Healthcare Pharmaceutical Retailers
PetMed Express, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $179.0 million, down 21.1% from fiscal 2025. In the quarter to June 2026, revenue fell 19.9%, EPS grew 83.0% and free cash flow grew 38.6%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
Follow PETS
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
21.41 | 54.72 | 55.30 | 104.09 | 111.08 | 118.72 | 103.76 | 100.53 | 77.94 | 58.73 |
Receivables |
1.91 | 2.32 | 3.28 | 1.74 | 1.91 | 2.59 | 3.84 | 2.54 | 2.29 | 1.81 |
Inventory |
13.61 | 16.21 | 28.56 | 19.02 | 32.46 | 34.42 | 17.88 | 21.37 | 23.34 | 20.23 |
Total current assets |
43.56 | 78.87 | 93.65 | 130.43 | 151.00 | 161.19 | 129.02 | 126.43 | 105.24 | 81.79 |
Property, Plant, Equpment (Net) |
26.33 | 28.86 | 26.66 | 26.18 | 24.46 | 25.45 | 25.45 | 27.14 | 28.74 | 30.16 |
Goodwill and Intangible Assets (Total) |
10.79 | 40.00 | 43.16 | 5.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 |
Long Term Assets (Tax, Deferred) |
— | — | 4.99 | 5.01 | 3.38 | — | — | — | — | — |
Total non-current assets |
37.63 | 69.83 | 76.24 | 37.05 | 28.70 | 26.31 | 26.31 | 28.00 | 29.60 | 31.02 |
Total Assets |
81.19 | 148.70 | 169.88 | 167.48 | 179.70 | 187.50 | 155.32 | 154.43 | 134.84 | 112.81 |
Accounts Payable |
20.91 | 23.56 | 37.02 | 25.21 | 27.50 | 39.55 | 19.66 | 16.28 | 15.27 | 15.22 |
Accrued Expenses |
7.67 | 11.71 | 7.06 | 6.19 | 4.59 | 5.39 | 4.21 | 2.35 | 2.84 | 2.48 |
Current Part of Taxes to Pay |
22.28 | 24.95 | 25.01 | 26.11 | 24.16 | — | 0.47 | — | — | 0.66 |
Current Revenue (Deferred) |
0.69 | 2.09 | 2.60 | — | — | — | — | — | — | — |
Total current liabilities |
52.03 | 62.77 | 72.16 | 57.51 | 56.25 | 44.94 | 24.34 | 18.63 | 18.11 | 18.36 |
Long Term Tax Liability (Deferred) |
0.18 | 0.26 | — | (0.63) | 0.94 | 1.28 | 0.97 | 1.12 | 1.00 | 1.09 |
Total non-current liabilities |
0.22 | 0.80 | 1.00 | 3.83 | 0.94 | 1.28 | 0.97 | 1.12 | 1.00 | 1.09 |
Total liabilities |
52.25 | 63.57 | 73.15 | 57.51 | 56.25 | 46.22 | 25.31 | 19.75 | 19.11 | 19.44 |
Additional Paid In Capital |
19.65 | 18.56 | 25.15 | 18.28 | 11.66 | 7.11 | 3.80 | 12.48 | 9.38 | 6.81 |
Preferred Stock (Total) |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Common Stock (Net) |
0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Retained Earnings |
9.26 | 66.54 | 71.56 | 91.66 | 111.76 | 134.14 | 126.18 | 122.17 | 106.32 | 86.53 |
Common Equity (Total) |
28.93 | 85.13 | 96.72 | 109.96 | 123.44 | 141.27 | 130.00 | 134.67 | 115.72 | 93.36 |
Shareholders Equity (Total) |
28.94 | 85.13 | 96.73 | 109.97 | 123.45 | 141.28 | 130.01 | 134.68 | 115.73 | 93.37 |
Shareholders Equity and Liabilities (Total) |
81.19 | 148.70 | 169.88 | 167.48 | 179.70 | 187.50 | 155.32 | 154.43 | 134.84 | 112.81 |
Shares (Common) |
21.39 | 20.66 | 21.15 | 21.08 | 20.98 | 20.27 | 20.17 | 20.67 | 20.60 | 20.53 |
Shares (Preferred) |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Shareholders Equity (Tangible) |
18.15 | 45.13 | 53.57 | 104.11 | 122.59 | 140.42 | 129.15 | 133.82 | 114.87 | 92.51 |
Net Debt |
(21.41) | (54.72) | (55.30) | (104.09) | (111.08) | (118.72) | (103.76) | (100.53) | (77.94) | (58.73) |